MedPath

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus

Phase 3
Completed
Conditions
Diabetes Mellitus, Non-Insulin-Dependent
Interventions
Drug: Placebo
Registration Number
NCT00035984
Lead Sponsor
AstraZeneca
Brief Summary

This is a multicenter, randomized, blinded, placebo-controlled study to assess the effects on glucose control of AC2993 as compared to placebo in patients with type 2 diabetes. Patients will be randomized into one of two AC2993 treatment arms or to placebo treatment and will continue with their required existing diabetes medications (metformin and a sulfonylurea) throughout the study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
734
Inclusion Criteria
  • Subjects with Type 2 diabetes mellitus
  • Treated with both metformin and a sulfonylurea at defined doses for at least 3 months prior to screening
  • BMI= 27-45 kg/m2
  • HbA1c value between 7.5% and 11%
Exclusion Criteria
  • Treated with oral anti-diabetic medications other than metformin and sulfonylurea within 3 months of screening
  • Patients treated previously with AC2993
  • Patients presently treated with insulin

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AC2993 5 mcg (0.02 mL)AC2993Placebo, then AC2993 5 mcg, then AC2993 5 mcg
AC2993 10mcg (0.04 mL)AC2993Placebo, then AC2993 5 mcg, then AC2993 10 mcg
Placebo 0.02 mLPlaceboPlacebo 0.02 mL, then Placebo 0.02 mL, then Placebo 0.02 mL
Placebo 0.04 mLPlaceboPlacebo 0.02 mL, then Placebo 0.02 mL, then Placebo 0.04 mL
Primary Outcome Measures
NameTimeMethod
Change in HbA1c from Baseline to Week 30Baseline (Day 1) to Week 30

Change in HbA1c from Baseline (Day 1) to study termination (Week 30)

Secondary Outcome Measures
NameTimeMethod
Change in HbA1c from baseline (Day 1) to each of the intermediate visitsBaseline (Day 1), Week 2, Week 4, Week 6, Week 12, Week 18, Week 24

Change in HbA1c from baseline, measured from Visit 3 (Day 1) to each of the intermediate visits (Baseline (Day 1), Week 2, Week 4, Week 6, Week 12, Week 18, and Week 24)

The number of subjects achieving HbA1c target values of < 7% and < 8% by Week 30Baseline (Day 1) and Week 30

The number of subjects achieving HbA1c target values of \< 7% and \< 8% by study termination (Week 30)

The number of subjects achieving HbA1c reductions of > 0.5% and > 1.0% by Week 30Baseline (Day 1), and Week 30

The number of subjects achieving HbA1c reductions of \> 0.5% and \> 1.0% by study termination (Week 30)

The time to achieve specific HbA1c target values of < 7% and < 8%Baseline (Day 1), Week 2, Week 4, Week 6, Week 12, Week 18, Week 24, Week 30

The time it takes subjects to achieve HbA1c target values of \< 7% and \< 8%

The time to achieve HbA1c reductions of 0.5% or more and >1.0% or moreBaseline (Day 1), Week 2, Week 4, Week 6, Week 12, Week 18, Week 24, Week 30

The time it takes subjects to achieve HbA1c reductions of 0.5% or more and \>1.0% or more

Change in body weight from Baseline to each intermediate visit and Week 30Baseline (Day 1), Week 2, Week 4, Week, 6, Week 12, Week 18, Week 24, Week 30

Change in body weight (kg) from Baseline to each intermediate visit and Week 30

Trial Locations

Locations (100)

Diabetes and Endocrinology Specialists

🇺🇸

Chesterfield, Missouri, United States

Holston Medical Group

🇺🇸

Kingsport, Tennessee, United States

University of Mississippi Medical Center

🇺🇸

Jackson, Mississippi, United States

Radiant Research-San Diego

🇺🇸

San Diego, California, United States

Veterans Medical Research Foundation

🇺🇸

San Diego, California, United States

Baptist Diabetes Associates

🇺🇸

Miami, Florida, United States

Indiana University Outpatient Clinical Research

🇺🇸

Indianapolis, Indiana, United States

UNC Diabetes Care Center

🇺🇸

Durham, North Carolina, United States

Utah Diabetes Center at the University of Utah

🇺🇸

Salt Lake City, Utah, United States

University of Texas Health Sciences Center-Texas Diabetes Institute

🇺🇸

San Antonio, Texas, United States

SAM Clinical Research

🇺🇸

San Antonio, Texas, United States

Salt Lake Research

🇺🇸

Salt Lake City, Utah, United States

Parkway Medical Center

🇺🇸

Birmingham, Alabama, United States

Henry Ford Health System

🇺🇸

Detroit, Michigan, United States

First Care Family Doctors

🇺🇸

Fayetteville, Arkansas, United States

Advanced Clinical Research Institute

🇺🇸

Anaheim, California, United States

Whittier Institute for Diabetes

🇺🇸

La Jolla, California, United States

Medical Research Unlimited

🇺🇸

Aventura, Florida, United States

Morton Plant Mease Health Care

🇺🇸

Clearwater, Florida, United States

Northwestern Memorial Physicians Group

🇺🇸

Chicago, Illinois, United States

Metabolic Research Institute, Inc.

🇺🇸

West Palm Beach, Florida, United States

Jupiter Research Institute

🇺🇸

Jupiter, Florida, United States

Kentucky Diabetes Center

🇺🇸

Lexington, Kentucky, United States

University of Hawaii-Diabetes Research Group

🇺🇸

Ewa Beach, Hawaii, United States

Central Kentucky Research Associates

🇺🇸

Lexington, Kentucky, United States

OU Health Sciences Center

🇺🇸

Oklahoma City, Oklahoma, United States

Thomas Jefferson University Diabetes Research Center

🇺🇸

Philadelphia, Pennsylvania, United States

University of Colorado-Barbara Davis Center for Childhood Diabetes

🇺🇸

Denver, Colorado, United States

Midwest Endocrinology Associates

🇺🇸

Milwaukee, Wisconsin, United States

Pinnacle Research Group

🇺🇸

Anniston, Alabama, United States

Extended Arm Physicians/ Southern Drug

🇺🇸

Montgomery, Alabama, United States

Southern Drug Research Network

🇺🇸

Tallassee, Alabama, United States

Physicians Group Research Clinic, LLC

🇺🇸

Little Rock, Arkansas, United States

St. Joseph Heritage Healthcare

🇺🇸

Fullerton, California, United States

Medical Group of Encino

🇺🇸

Encino, California, United States

Richard Cherlin, M.D.

🇺🇸

Los Gatos, California, United States

Comprehensive Diabetes-Endocrine Medical Associates

🇺🇸

Redwood City, California, United States

Creekside Endocrine Associates

🇺🇸

Denver, Colorado, United States

Medstar Clinical Research

🇺🇸

Washington, District of Columbia, United States

George Washington University

🇺🇸

Washington, District of Columbia, United States

Clinical Research of West Florida, Inc.

🇺🇸

Clearwater, Florida, United States

Northeast Florida Endocrine & Diabetes Research

🇺🇸

Jacksonville, Florida, United States

Tallahassee Endocrine Associates

🇺🇸

Tallahassee, Florida, United States

Columbus Metabolic Foundation

🇺🇸

Columbus, Georgia, United States

University Primary Care Center at Belvidere

🇺🇸

Belvidere, Illinois, United States

American Health Network

🇺🇸

Indianapolis, Indiana, United States

Lipid, Atherosclerosis & Metabolic Clinic

🇺🇸

Kansas City, Kansas, United States

University of Kentucky Metabolic Research Group

🇺🇸

Lexington, Kentucky, United States

University of Maryland-Joslin Diabetes Center

🇺🇸

Baltimore, Maryland, United States

Grand Rapids Associated Interns

🇺🇸

Grand Rapids, Michigan, United States

International Diabetes Center

🇺🇸

Minneapolis, Minnesota, United States

Clinica Research Inc.

🇺🇸

Waltham, Massachusetts, United States

Mercury Street Medical

🇺🇸

Butte, Montana, United States

Radiant Research-St. Louis

🇺🇸

St. Louis, Missouri, United States

Midwest Pharmaceutical Research

🇺🇸

St. Peters, Missouri, United States

Lovelace Scientific Resources-Las Vegas

🇺🇸

Las Vegas, Nevada, United States

St. Lukes Roosevelt Hospital

🇺🇸

New York, New York, United States

Rochester Clinical Research

🇺🇸

Rochester, New York, United States

DOCS at Beth Israel Medical Center

🇺🇸

Yonkers, New York, United States

Charlotte Clinical Research

🇺🇸

Charlotte, North Carolina, United States

Unifour Medical Research

🇺🇸

Hickory, North Carolina, United States

New Hanover Medical Research Associates

🇺🇸

Wilmington, North Carolina, United States

Radiant Research-Columbus

🇺🇸

Columbus, Ohio, United States

Medford Medical Clinic

🇺🇸

Medford, Oregon, United States

University Mednet

🇺🇸

Mentor, Ohio, United States

Albert Einstein Medical Center

🇺🇸

Philadelphia, Pennsylvania, United States

Physicians for Clinical Research

🇺🇸

Camp Hill, Pennsylvania, United States

Philadelphia Health Associates

🇺🇸

Philadelphia, Pennsylvania, United States

CNS Clinical Trials

🇺🇸

Chester, South Carolina, United States

Coastal Carolina Research Center

🇺🇸

Mt. Pleasant, South Carolina, United States

The Endocrine Clinic

🇺🇸

Memphis, Tennessee, United States

Mid State Endocrine Associates

🇺🇸

Nashville, Tennessee, United States

Israel A. Hartman, M.D.

🇺🇸

Arlington, Texas, United States

Dallas Diabetes and Endocrinology Research Center

🇺🇸

Dallas, Texas, United States

Texas Tech University Health Sciences-Internal Medicine

🇺🇸

El Paso, Texas, United States

North Texas Clinical Research

🇺🇸

Irving, Texas, United States

Medical Associates of Northern Virginia

🇺🇸

Arlington, Virginia, United States

West Olympia Internal Medicine

🇺🇸

Olympia, Washington, United States

Rockwood Clinic

🇺🇸

Spokane, Washington, United States

University of Wisconsin West Clinic

🇺🇸

Madison, Wisconsin, United States

Cook County Hospital

🇺🇸

Chicago, Illinois, United States

Illinois Center for Clinical Trials

🇺🇸

Chicago, Illinois, United States

Internal Medicine Associates

🇺🇸

Ft. Myers, Florida, United States

Valley Research

🇺🇸

Fresno, California, United States

East Bay Clinical Trial Center

🇺🇸

Concord, California, United States

Diablo Clinical Research

🇺🇸

Walnut Creek, California, United States

Medical Arts Research Collaborative

🇺🇸

Excelsior Springs, Missouri, United States

Dr. Martinez Medical Clinic

🇺🇸

Moreno Valley, California, United States

Comprehensive NeuroScience Inc.

🇺🇸

Sarasota, Florida, United States

Lisa Abbott, MD

🇺🇸

Reno, Nevada, United States

Mid Missouri Research Specialists, Inc.

🇺🇸

Rolla, Missouri, United States

SUNY Downstate

🇺🇸

Brooklyn, New York, United States

Diabetes and Glandular Disease Clinic

🇺🇸

San Antonio, Texas, United States

New Orleans Center for Clinical Research

🇺🇸

New Orleans, Louisiana, United States

MedResearch, Inc.

🇺🇸

Louisville, Kentucky, United States

St Lukes Lipid and Diabetes Research Center

🇺🇸

Kansas City, Missouri, United States

Ochsner Clinic

🇺🇸

New Orleans, Louisiana, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

Clin Sci International

🇺🇸

Gainesville, Florida, United States

Radiant Research

🇺🇸

Portland, Oregon, United States

© Copyright 2025. All Rights Reserved by MedPath